Magenta Therapeutics, Inc. License Agreements
6 Contracts & Agreements
- Amendment No. 3, effective as of August 1, 2022, to the Exclusive Research, Development Option and License Agreement by and between the Registrant and Heidelberg Pharma Research... (Filed With SEC on November 3, 2022)
- Amendment, effective as of July 4, 2019, pursuant to the Exclusive Research, Development Option and License Agreement by and between the Registrant and Heidelberg Pharma Research... (Filed With SEC on November 13, 2019)
- Letter Agreement, effective as of February 28, 2019, by and between the Registrant and Heidelberg Pharma Research GmbH relating to the Exclusive Research, Development Option and... (Filed With SEC on April 29, 2019)
- Exclusive Research, Development Option and License Agreement by and between Heidelberg Pharma Research GmbH and the Registrant, dated as of March 1, 2018 (Filed With SEC on May 24, 2018)
- License Agreement by and between Novartis International Pharmaceutical Ltd. and the Registrant, dated as of April 3, 2017 (Filed With SEC on May 24, 2018)
- License Agreement by and between President and Fellows of Harvard College and the Registrant, dated as of November 2, 2016 (Filed With SEC on May 24, 2018)
